Stanford University
Showing 3,601-3,610 of 34,516 Results
-
Anna Bui
Postdoctoral Scholar, Chemistry
BioAnna Bui is a theoretical chemist who studies how fluids behave across length scales, from molecular interactions to macroscopic flow. Her research combines statistical physics, computer simulation, and machine learning to develop predictive theories for water, ions, and electrolytes, with applications in energy, nanofluidics, and functional materials. She obtained her PhD in 2026 at the University of Cambridge, where she developed multiscale frameworks linking microscopic solvation and transport to collective phenomena. At Stanford, she uses machine learning to enable inverse design of biologically inspired functions in ionic materials for energy storage and neuromorphic computing.
-
Nam Quoc Bui
Clinical Associate Professor, Medicine - Oncology
BioDr. Bui is a Clinical Associate Professor of Medicine at the Stanford Cancer Institute and a specialist in Sarcoma. Dr. Bui earned an undergraduate degree in Computer Science at Stanford University and went on to earn his medical degree from the University of Texas Southwestern Medical Center. He completed Internal Medicine residency at Stanford Hospital and Hematology/Oncology fellowship at the University of California San Diego, where he performed extensive research in bioinformatics to analyze tumor sequencing data.
He is involved in numerous sarcoma clinical trials, leading efforts to take new therapeutics from the lab to clinical practice. His research background and interests are in the field of bioinformatics as applied to large data sets and the study of novel compounds in rare malignancies. He also is involved in education at the Stanford University School of Medicine, serving as a lecturer and mentor to medical students, residents, and oncology fellows. Dr. Bui is the founding Editor-in-Chief of the journal “Current Problems in Cancer: Case Reports”, an international, peer-reviewed journal that publishes groundbreaking cases that give insight into redefining concepts in cancer. He also serves as the Chair of the Data Safety Monitoring Committee at the Stanford Cancer Institute, overseeing the board that reviews all investigator-initiated cancer trials run at Stanford.
